Bhaktraj Singh's profile

Biotechnology and Personalized Medicine

An accomplished senior executive with over 25 years of experience in real estate development, technology, and business services, Bhaktraj Singh serves as the CEO of the Hazelton Group, a Toronto, Canada-based real estate development company. In addition to his role as CEO, Bhaktraj “Raj” Singh follows the latest advancements and emerging trends in AI and biotechnology research and start-ups.

Biotechnology is a scientific field that leverages biomolecular and cellular processes to create food, healthcare products, biofuels, and other materials. In the healthcare sector, a significant trend in biotechnology is personalized medicine, which uses an individual's genetic makeup to design a therapy tailored to their specific needs.

Personalized medicine also uses genetic makeup to analyze the susceptibility to certain diseases. Once healthcare providers identify these diseases, they can formulate preemptive regimens and lifestyle changes to prevent or slow the diseases. Identifying medical issues from a patient's genetic profile drives holistic treatment.

Biotechnology and Personalized Medicine
Published:

Biotechnology and Personalized Medicine

Published:

Creative Fields